Ignite Creation Date:
2025-12-24 @ 5:16 PM
Ignite Modification Date:
2025-12-28 @ 11:38 AM
Study NCT ID:
NCT02451150
Status:
COMPLETED
Last Update Posted:
2016-04-07
First Post:
2015-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With Hypertension
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08
Start Date Type:
None
Primary Completion Date:
2015-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-19
First Submit QC Date:
None
Study First Post Date:
2015-05-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-08
Results First Submit QC Date:
None
Results First Post Date:
2016-04-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-08
Last Update Post Date:
2016-04-07
Last Update Post Date Type:
ESTIMATED